Get Wegovy Medication Online

Wegovy weight-loss results

In pivotal trials, the average adult lost roughly 15% of body weight over about 16 months on Wegovy plus lifestyle support, with many losing more and some less. Appetite typically drops within the first weeks, while visible weight change builds over the first two to three months and continues more gradually thereafter.

Beyond the scale, Wegovy has been shown to improve cardiometabolic markers and, in people with heart disease, to reduce cardiovascular events. As with all GLP-1 therapy, weight regain is common if the medication is stopped, because appetite regulation returns to baseline. We therefore treat Wegovy as part of a long-term strategy and help you build habits that support maintenance.

What is Wegovy?

Wegovy is Novo Nordisk's semaglutide product developed and approved for one purpose: chronic weight management in adults (and, more recently, certain adolescents). Unlike Ozempic, which is approved for type 2 diabetes, Wegovy is titrated to a higher maintenance dose because the goal is sustained appetite reduction and weight loss. In 2024 the FDA also approved Wegovy to reduce the risk of major cardiovascular events in adults with established heart disease who are overweight or have obesity.

From a clinical standpoint, Wegovy represents an important shift: obesity is now treated as the chronic, relapsing medical condition it is, with a medication that targets its underlying physiology. That framing matters, because it moves the conversation away from blame and toward evidence-based care. Wegovy is a once-weekly injection used together with reduced-calorie nutrition and increased physical activity.

As with all of these medicines, Wegovy is prescription-only and requires a proper medical evaluation. The right candidate and careful follow-up are what make treatment both safe and effective.

How Wegovy helps you lose weight

Wegovy works by delivering a long-acting form of GLP-1, the gut hormone that signals satiety. It quiets appetite at the level of the brain, slows how quickly the stomach empties, and reduces the cravings and "food noise" that sabotage so many weight-loss efforts. At the maintenance dose, these effects are strong enough that most patients naturally eat less without the constant feeling of deprivation that doomed previous diets.

In the STEP clinical trial program, adults taking Wegovy alongside lifestyle changes lost on average about 15% of their starting body weight over roughly 68 weeks, compared with about 2.4% on placebo — a difference that translates into meaningful improvements in blood pressure, blood sugar, lipids, and quality of life for many patients.

Wegovy does not melt fat directly; it changes the appetite and fullness signals that drive how much you eat. That is why nutrition quality, protein intake to preserve muscle, and physical activity remain essential parts of a successful program.

Is Wegovy right for you?

Wegovy is specifically indicated for weight management. Our clinicians generally consider it for adults who meet criteria such as:

• A BMI of 30 or higher (obesity), or
• A BMI of 27 or higher (overweight) with at least one weight-related condition such as hypertension, dyslipidemia, prediabetes, type 2 diabetes, or sleep apnea
• Established cardiovascular disease with overweight or obesity (for cardiovascular risk reduction)
• A documented history of difficulty achieving lasting weight loss
• No contraindications identified on medical review

Our Wegovy program & dosing support

Wegovy uses a structured, gradual titration designed to reach an effective maintenance dose while limiting nausea. The schedule typically begins at a small weekly dose for the first month and increases approximately every four weeks over several months until you reach the maintenance dose your clinician recommends. If side effects appear, your provider can slow the schedule — comfort and safety guide the pace, not the calendar.

Here is how a Wegovy program works with us:

Your first 90 days on Wegovy

The first 90 days on Wegovy are a deliberate, gradual climb. The medication uses a structured escalation, starting low and stepping up roughly every four weeks, specifically to limit side effects rather than to rush results. Early on you may notice appetite softening before significant weight change appears, which is exactly what we expect. As you move through the dose steps, portions naturally shrink and fullness arrives sooner. Nausea or digestive changes tend to cluster in the days right after each increase and usually settle quickly with smaller meals, adequate protein, and good hydration. We check in at each step and slow the pace if your body needs more time. By the end of three months you typically are not yet at the maintenance dose, and that is fine; this phase is about building tolerance and habits so the more substantial weight changes that follow are sustainable rather than abrupt.

Wegovy compared with other options

Wegovy is the weight-management version of semaglutide; Ozempic and Rybelsus are the diabetes-focused versions of the same molecule. Tirzepatide as Zepbound is the leading alternative for weight and, in head-to-head and indirect comparisons, has shown greater average weight loss for some patients, though both share a similar side-effect pattern. Your clinician helps you choose based on your history, tolerance, and goals.

Combining Wegovy with nutrition and movement

Wegovy is built for chronic weight management, and the clinical trials that earned its approval paired the medication with reduced-calorie eating and increased activity for a reason. The drug makes a calorie deficit feel achievable instead of miserable, but the habits you build during treatment are what protect your results later. We emphasize protein at every meal to preserve lean muscle, strength work a couple of times a week, and enough fiber and water to keep digestion comfortable as gastric emptying slows. Because appetite drops sharply, planning meals ahead prevents the trap of under-eating all day and then feeling depleted. Sleep and stress management quietly influence weight too, and we fold those into the conversation. Think of Wegovy as lowering the difficulty of the game rather than playing it for you; the routines you practice now become the scaffolding that holds your progress in place over the long term.

Monitoring, follow-up, and staying on track

Because Wegovy is a long-term weight-management medication, we treat your care as an ongoing partnership. After your first dose we check tolerance within a week or two, then reassess at each of the scheduled escalations up to your maintenance dose. Your clinician monitors for persistent nausea, signs of gallbladder problems, changes in heart rate, and any concerning abdominal pain, slowing your titration if your body needs more time. We track your weight trajectory over weeks rather than fixating on daily fluctuations, and we revisit goals as you progress. If you reach a plateau, that is a normal physiological event, not a failure, and we problem-solve it together. Should side effects become limiting, we can adjust the dose or pace. Between appointments you can reach your care team, so questions about symptoms or dosing never have to wait.

Common myths about Wegovy

Wegovy cost & getting started

Programs start at $75 per month with a free, same-day initial consultation. Your clinician will explain exactly what is included — medication, discreet shipping, and follow-up care — before you decide. There is no obligation to continue, and our pricing is designed to be clear and accessible.